Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Gilead Sciences' cell therapy Kite Pharma has ... It's the second deal in a matter of days for Shoreline, coming after China's BeiGene paid $45 million upfront to harvest the San Diego-based ...

Salesforce stock won an upgrade to buy from TD Cowen, which pointed to momentum for its new artificial intelligence platform.

AstraZeneca and Gilead are both staying tight-lipped over rumoured merger talks, but the consensus among analysts seems to be that there would anyway be little value in such a deal. On Sunday ...

Selective stock-picking and conviction drove HB Biotech’s strong 2024 performance. Read our insights on navigating today’s ...

Teva Pharmaceutical Industries Ltd. ADR-1.19% $24.61B ...